Kit for detection of RhD antigen (RHD)

Fetal RHD genotyping from maternal blood allows targeted anti-D prophylaxis in RhD-negative pregnant women without anti-D alloimmunization, avoiding unnecessary exposure to anti-D immunoglobulin.

Key Features

• Specific – Sensitive – Reliable – Robust

• Applicable from gestation week 12

• All-in-one CE-IVD kit (submitted for IVDR certification)

• Multiplex amplification and detection of human RHD gene exons 5, 7, and 10

• Detection of RHD variants possible due to multiplex format

• Internal Positive Control (IPC) system to exclude false-negative results using a short synthetic DNA fragment (<120 bp) imitating circulating fetal DNA

• Rapid hot-start Taq DNA polymerase

FetoGnost® Kit Control (RUO)

• For validation of extraction methods

• Kit for detection of cell-free fetal DNA (cffDNA)

• Amplification and detection of one maternal DNA marker and two fetal DNA markers

• Restriction enzyme digestion system included